{ "abstract": "Purpose: To comprehensively evaluate the predictive value of neurovascular retinal measurements for incident cancer.\n\nDesign: Population-based, prospective cohort study.\n\nParticipants: A total of 41 424 participants with eligible color fundus photography and OCT data from the UK Biobank.\n\nMethods: Retinomics were derived from multimodal retinal imaging of the UK Biobank, comprising 156 retinal features. Four Cox regression models were developed: model 1 (age and sex), model 2 (model 1 + ethnicity and lifestyle factors), model 3 (model 1 + retinomics), and model 4 (full model). Least Absolute Shrinkage and Selection Operator regression was used to select relevant retinal biomarkers, tailored to each cancer type. Predictive performance was assessed via the concordance index (C-index), detection rate (DR), and positive likelihood ratio (LR+). Detection rate and LR+ were evaluated at a false-positive rate of 10%. Calibration was assessed by calibration slope and calibration-in-the-large (CITL). Hazard ratios (HRs) were used to stratify cancer risk between high- and low-risk groups identified by retinomics.\n\nMain Outcome Measures: Incident diagnoses of any cancer and specific types: breast, uterine/endometrial, prostate, esophageal, lung, stomach, colon, rectal, skin, and other cancers.\n\nResults: Among 41 424 participants, 3633 (8.77%) developed cancer over 12.5 years of follow-up. Incorporating retinomics significantly improved the C-index, DR, and LR+ across most cancer types, with the C-index values for model 4 ranging from 0.581 to 0.885 across individual cancers. The largest gain was observed in uterine/endometrial cancer (ΔC-index = 0.220; 95% confidence interval [CI]: 0.119–0.327]; ΔDR = 40%; ΔLR+ = 4.003), although this finding is based on only 20 incident cases and should be interpreted with caution. Calibration analysis demonstrated good agreement between predicted and observed risks across all models (slope range: 0.635–1.233; CITL near 0). The high-risk group identified by retinomics exhibited a 7% higher annual cancer risk (HR = 1.07; 95% CI: 1.06–1.08; P < 0.001), accumulating to a nearly threefold higher risk over 12 years.\n\nConclusions: Retinomics demonstrates predictive value for cancer incidence, with cancer type–specific biomarker selection enhancing accuracy. These findings highlight the transformative potential of retinal imaging as a scalable, noninvasive approach for early cancer risk profiling and proactive prevention.\n\nFinancial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.", "abstract_shown": true, "affiliations": [ "School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong.", "Research Centre for SHARP Vision, The Hong Kong Polytechnic University, Kowloon, Hong Kong.", "Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.", "Department of Surgery (Ophthalmology), The University of Melbourne, Melbourne, Australia.", "Department of Ophthalmology, Guangdong Eye Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.", "Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.", "InnoHK, Centre for Eye and Vision Research, Kowloon, Hong Kong.", "PolyU-Stanford Joint Research Centre for Longitudinal Deep Omics, The Hong Kong Polytechnic University, Kowloon, Hong Kong." ], "article_type": "research article", "arxiv": null, "author_total": 7, "authors": [ { "affs": [ 0, 1 ], "name": "Selena Wei Zhang" }, { "affs": [ 2, 3 ], "name": "Mayinuer Yusufu" }, { "affs": [ 0, 1 ], "name": "Xia Gong" }, { "affs": [ 0, 1, 2, 3, 4 ], "name": "Xianwen Shang" }, { "affs": [ 5 ], "name": "Feng Gao", "orcid": "0000-0002-0500-5527" }, { "affs": [ 0, 1, 6, 7 ], "name": "Mingguang He" }, { "affs": [ 0, 1, 6, 7 ], "name": "Danli Shi" } ], "bibtex": "https://research.draconitic.com/paper/a50mw7fm4mfte.bib", "cited_by": 0, "doi": "10.1016/j.xops.2026.101413", "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13696361/", "id": "a50mw7fm4mfte", "issns": [ "2666-9145" ], "landing_url": "https://doi.org/10.1016/j.xops.2026.101413", "language": "en", "licence": "CC-BY-NC-ND-4.0", "licence_label": "CC BY-NC-ND 4.0", "licence_source": "article", "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/", "metadata_licence": null, "native_subjects": [ [ "heading", "Original Article" ], [ "openalex", "2741|Retinal Imaging and Analysis" ] ], "openalex": "W7213924893", "pdf_url": "https://europepmc.org/articles/PMC13696361?pdf=render", "pmcid": "PMC13696361", "pmid": "42935868", "published": "2026-09-21", "publisher": "Elsevier", "ris": "https://research.draconitic.com/paper/a50mw7fm4mfte.ris", "sources": [ { "first_seen": "2026-10-30T12:17:43Z", "native_id": "PMC13696361", "source": "pmc", "url": "https://doi.org/10.1016/j.xops.2026.101413" }, { "first_seen": "2026-10-30T12:22:24Z", "native_id": "MED:42935868", "source": "europepmc", "url": "https://europepmc.org/article/MED/42935868" } ], "subjects": [ { "field": "medicine", "origin": "openalex:2741|Retinal Imaging and Analysis", "subfield": "imaging" } ], "title": "Neurovascular Retinomics for Noninvasive Profiling of Cancer Risk", "title_text": "Neurovascular Retinomics for Noninvasive Profiling of Cancer Risk", "type": "peer-reviewed", "updated_at": "2026-10-30T12:33:42Z", "url": "https://research.draconitic.com/paper/a50mw7fm4mfte", "venue": "Ophthalmology Science", "versions": [] }